Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,385 public trials 2,846 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

Institutional Registry of Rare Diseases

NCT06573723

Conditions: Abnormalities, Multiple, Adrenal Gland Diseases, Adrenal Hyperplasia, Congenital, +144 more
Locations: Hospital Italiano de Buenos Aires Buenos Aires, Argentina

View Trial Details

Recruiting

Isatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma

NCT05922501

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +18 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

JY232(JY232) Injection in Relapsed/Refractory Multiple Myeloma

NCT07336823

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Foshan First People's Hospital Foshan, Guangdong, China

View Trial Details

Recruiting

Prognostic Value of NETosis Markers for Thrombosis During Myeloproliferative Neoplasms (AVATARE)

NCT07119970

Conditions: Bone Marrow Diseases, Cardiovascular Diseases, Embolism and Thrombosis, +6 more
Locations: CHU d'Angers, Service des maladies du Sang Angers, France

CH de la Côte Basque, Service Hématologie Bayonne, France

CHU de Bordeaux, Service Hématologie Biologique Bordeaux, France

CHU de Bordeaux, Service Hématologie Clinique et Thérapie Cellulaire Bordeaux, France

View all 15 locations

View Trial Details

Recruiting

Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC

NCT04528355

Conditions: Adrenal Gland Diseases, Adrenal Insufficiency, Adrenoleukodystrophy, +119 more
Locations: UPMC Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Recruiting

Study of Naive HBI0101 CAR-T Therapy in Relapsed/Refractory Multiple Myeloma

NCT07333430

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Hadassah MO, Jerusalem, 9574869 Jerusalem, Israel

View Trial Details

Recruiting

Venetoclax to Augment Epigenetic Modification and Chemotherapy

NCT05317403

Conditions: Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Hematologic Diseases, +6 more
Locations: Children's Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Recruiting

A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)

NCT06163430

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +13 more
Locations: University of Alabama Medicine (UAB Medicine) Birmingham, Alabama, United States

Banner MD Anderson Cancer Center Gilbert, Arizona, United States

UC Irvine Health Orange, California, United States

Rocky Mountain Cancer Centers, LLP Lone Tree, Colorado, United States

View all 54 locations

View Trial Details

Recruiting

Mezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma in Patients With Extramedullary Disease

NCT06627751

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Extramedullary Disease in Multiple Myeloma, +15 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Recruiting

CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial

NCT06765876

Conditions: Blastic Plasmacytoid Dendritic Cell Neoplasm, Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), Bone Marrow Diseases, +23 more
Locations: Ustav hematologie a krevni transfuze / Institute of Hematology and Blood Transfusion Prague, Czechia

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions